{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:11:52Z","timestamp":1787965912498,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Barts Charity Healthcare Professional Clinical Research Training Fellowship","award":["G-002779"],"award-info":[{"award-number":["G-002779"]}]},{"name":"MRC Population and Systems Research Grant","award":["MR\/X021173\/1"],"award-info":[{"award-number":["MR\/X021173\/1"]}]},{"name":"NIHR Advance Fellowship","award":["NIHR300098"],"award-info":[{"award-number":["NIHR300098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>\n                      Silver-Russell syndrome (SRS) is a complex multisystem condition requiring timely diagnosis for appropriate management. A clinical diagnosis is made in individuals scoring\u2009\u2265\u20094 Netchine-Harbison Clinical Scoring System (NH-CSS) criteria, with (epi)genetic investigations undertaken in those with NH-CSS\u2009\u2265\u20093 and strong clinical suspicion. Monogenic variants in imprinted (\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      and\n                      <jats:italic>IGF2<\/jats:italic>\n                      ) and non-imprinted (\n                      <jats:italic>HMGA2<\/jats:italic>\n                      and\n                      <jats:italic>PLAG1<\/jats:italic>\n                      ) genes are recognised as rare causes of SRS. The frequency of associated phenotypes is unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We evaluated the suitability of SRS as an umbrella term for these (epi)genotypes by identifying key clinical features and assessing the validity of NH-CSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An extensive literature search identified 22\n                      <jats:italic>IGF2,<\/jats:italic>\n                      18\n                      <jats:italic>HMGA2<\/jats:italic>\n                      , 11\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      and 11\n                      <jats:italic>PLAG1<\/jats:italic>\n                      published reports.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>Clinical phenotypes including the NH-CSS criteria were interrogated to assess (dis)similarity between the molecular subgroups of SRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Strict adherence to the NH-CSS identified clinical SRS in 91%\n                      <jats:italic>IGF2,<\/jats:italic>\n                      82%\n                      <jats:italic>CDKN1C,<\/jats:italic>\n                      78%\n                      <jats:italic>HMGA2<\/jats:italic>\n                      and 45%\n                      <jats:italic>PLAG1<\/jats:italic>\n                      affected individuals. Relative macrocephaly was observed in 82%\n                      <jats:italic>IGF2<\/jats:italic>\n                      , 82%\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      , 44%\n                      <jats:italic>HMGA2<\/jats:italic>\n                      , and 27%\n                      <jats:italic>PLAG1<\/jats:italic>\n                      affected individuals. Prominent forehead was reported in 100%\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      , 91%\n                      <jats:italic>IGF2<\/jats:italic>\n                      , 72%\n                      <jats:italic>HMGA2<\/jats:italic>\n                      , and 64%\n                      <jats:italic>PLAG1<\/jats:italic>\n                      and body asymmetry in 23%\n                      <jats:italic>IGF2<\/jats:italic>\n                      and 11%\n                      <jats:italic>HMGA2<\/jats:italic>\n                      affected individuals. Clinical features not typically associated with SRS included: microcephaly, challenging behaviour, cardiac abnormalities, cleft palate, and asthma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The NH-CSS missed 9\u201355% of monogenic SRS. The diverse phenotypes of\n                      <jats:italic>PLAG1, CDKN1C, HMGA2<\/jats:italic>\n                      and\n                      <jats:italic>IGF2<\/jats:italic>\n                      variants may hinder a clinical diagnosis of SRS. These rarer (epi)genotypes could be considered as distinct entities.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-025-02023-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:11:49Z","timestamp":1766412709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Silver-Russell syndrome secondary to rare (epi)genotypes exhibits phenotypic heterogeneity challenging clinical diagnosis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9941-3161","authenticated-orcid":false,"given":"Uttara","family":"Kurup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-5051","authenticated-orcid":false,"given":"David B. N.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-3866","authenticated-orcid":false,"given":"Avinaash V.","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-2273","authenticated-orcid":false,"given":"Miho","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-6320","authenticated-orcid":false,"given":"Justin H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1931","authenticated-orcid":false,"given":"Helen L.","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2023_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae423","author":"U Kurup","year":"2024","unstructured":"Kurup U, Lim DBN, Palau H, Maharaj AV, Ishida M, Davies JH, et al. Approach to the patient with suspected Silver-Russell syndrome. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae423.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jmedgenet-2014-102979","volume":"52","author":"S Azzi","year":"2015","unstructured":"Azzi S, Salem J, Thibaud N, Chantot-Bastaraud S, Lieber E, Netchine I, et al. A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome. J Med Genet. 2015;52:446\u201353.","journal-title":"J Med Genet"},{"key":"2023_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.36.11.837","volume":"36","author":"SM Price","year":"1999","unstructured":"Price SM, Stanhope R, Garrett C, Preece MA, Trembath RC. The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med Genet. 1999;36:837\u201342.","journal-title":"J Med Genet"},{"key":"2023_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling EL, Brioude F, Lokulo-Sodipe O, O\u2019Connell SM, Salem J, Bliek J, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017;13:105\u201324.","journal-title":"Nat Rev Endocrinol"},{"key":"2023_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng1629","volume":"37","author":"C Gicquel","year":"2005","unstructured":"Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet. 2005;37:1003\u20137.","journal-title":"Nat Genet"},{"key":"2023_CR6","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1210\/jc.2007-0354","volume":"92","author":"I Netchine","year":"2007","unstructured":"Netchine I, Rossignol S, Dufourg M-N, Azzi S, Rousseau A, Perin L, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab. 2007;92:3148\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ejmg.2006.03.001","volume":"49","author":"N Sch\u00f6nherr","year":"2006","unstructured":"Sch\u00f6nherr N, Meyer E, Eggermann K, Ranke MB, Wollmann HA, Eggermann T. (Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: but are they generally involved in growth retardation? Eur J Med Genet. 2006;49:414\u20138.","journal-title":"Eur J Med Genet"},{"key":"2023_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/jmedgenet-2013-101691","volume":"50","author":"F Brioude","year":"2013","unstructured":"Brioude F, Oliver-Petit I, Blaise A, Praz F, Rossignol S, Le Jule M, et al. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J Med Genet. 2013;50:823\u201330.","journal-title":"J Med Genet"},{"key":"2023_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJMoa1415227","volume":"373","author":"M Begemann","year":"2015","unstructured":"Begemann M, Zirn B, Santen G, Wirthgen E, Soellner L, B\u00fcttel H-M, et al. Paternally inherited IGF2 mutation and growth restriction. N Engl J Med. 2015;373:349\u201356.","journal-title":"N Engl J Med"},{"key":"2023_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejmg.2009.03.001","volume":"52","author":"K Buysse","year":"2009","unstructured":"Buysse K, Reardon W, Mehta L, Costa T, Fagerstrom C, Kingsbury DJ, et al. The 12q14 microdeletion syndrome: additional patients and further evidence that HMGA2 is an important genetic determinant for human height. Eur J Med Genet. 2009;52:101\u20137.","journal-title":"Eur J Med Genet"},{"key":"2023_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/gim.2017.105","volume":"20","author":"W Abi Habib","year":"2018","unstructured":"Abi Habib W, Brioude F, Edouard T, Bennett JT, Lienhardt-Roussie A, Tixier F, et al. Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction. Genet Med. 2018;20:250\u20138.","journal-title":"Genet Med"},{"key":"2023_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/jmg.2010.079111","volume":"47","author":"EL Wakeling","year":"2010","unstructured":"Wakeling EL, Amero SA, Alders M, Bliek J, Forsythe E, Kumar S, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet. 2010;47:760\u20138.","journal-title":"J Med Genet"},{"key":"2023_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00945-y","volume":"12","author":"G Binder","year":"2020","unstructured":"Binder G, Ziegler J, Schweizer R, Habhab W, Haack TB, Heinrich T, et al. Novel mutation points to a hot spot in CDKN1C causing Silver-Russell syndrome. Clin Epigenetics. 2020;12:152.","journal-title":"Clin Epigenetics"},{"key":"2023_CR14","volume":"2019","author":"AH Sabir","year":"2019","unstructured":"Sabir AH, Ryan G, Mohammed Z, Kirk J, Kiely N, Thyagarajan M, et al. Familial Russell-Silver syndrome like phenotype in the PCNA domain of the CDKN1C gene, a further case. Case Rep Genet. 2019;2019:1398250.","journal-title":"Case Rep Genet"},{"key":"2023_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jmedgenet-2021-107699","volume":"59","author":"ASN Alhendi","year":"2022","unstructured":"Alhendi ASN, Lim D, McKee S, McEntagart M, Tatton-Brown K, Temple IK, et al. Whole-genome analysis as a diagnostic tool for patients referred for diagnosis of Silver-Russell syndrome: a real-world study. J Med Genet. 2022;59:613\u201322.","journal-title":"J Med Genet"},{"key":"2023_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00865-x","volume":"12","author":"T Inoue","year":"2020","unstructured":"Inoue T, Nakamura A, Iwahashi-Odano M, Tanase-Nakao K, Matsubara K, Nishioka J, et al. Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients. Clin Epigenetics. 2020;12:86.","journal-title":"Clin Epigenetics"},{"key":"2023_CR17","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.12998\/wjcc.v11.i19.4655","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Chen L-N, He H-L. CDKN1C gene mutation causing familial Silver-Russell syndrome: a case report and review of literature. World J Clin Cases. 2023;11:4655\u201363.","journal-title":"World J Clin Cases"},{"key":"2023_CR18","doi-asserted-by":"publisher","first-page":"E2117","DOI":"10.1210\/jc.2014-1949","volume":"99","author":"SL Kerns","year":"2014","unstructured":"Kerns SL, Guevara-Aguirre J, Andrew S, Geng J, Guevara C, Guevara-Aguirre M, et al. A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes. J Clin Endocrinol Metab. 2014;99:E2117\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz034","author":"Y Masunaga","year":"2020","unstructured":"Masunaga Y, Inoue T, Yamoto K, Fujisawa Y, Sato Y, Kawashima-Sonoyama Y, et al. IGF2 mutations. J Clin Endocrinol Metab. 2020. https:\/\/doi.org\/10.1210\/clinem\/dgz034.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2017.00105","author":"D Liu","year":"2017","unstructured":"Liu D, Wang Y, Yang X-A, Liu D. De novo mutation of paternal IGF2 gene causing Silver-Russell syndrome in a sporadic patient. Front Genet. 2017. https:\/\/doi.org\/10.3389\/fgene.2017.00105.","journal-title":"Front Genet"},{"key":"2023_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/humu.23253","volume":"38","author":"K Yamoto","year":"2017","unstructured":"Yamoto K, Saitsu H, Nakagawa N, Nakajima H, Hasegawa T, Fujisawa Y, et al. De novo IGF2 mutation on the paternal allele in a patient with Silver-Russell syndrome and ectrodactyly. Hum Mutat. 2017;38:953\u20138.","journal-title":"Hum Mutat"},{"key":"2023_CR22","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/ajmg.a.40502","volume":"176","author":"C Poulton","year":"2018","unstructured":"Poulton C, Azmanov D, Atkinson V, Beilby J, Ewans L, Gration D, et al. Silver Russel syndrome in an aboriginal patient from Australia. Am J Med Genet A. 2018;176:2561\u20133.","journal-title":"Am J Med Genet A"},{"key":"2023_CR23","doi-asserted-by":"crossref","unstructured":"Rockstroh D, Pf\u00e4ffle H, Le Duc D, R\u00f6\u00dfler F, Schlensog-Schuster F, Heiker JT, et al. A new p.(Ile66Serfs*93) IGF2 variant is associated with pre- and postnatal growth retardation. Eur J Endocrinol. 2019;180:K1\u201313.","DOI":"10.1530\/EJE-18-0601"},{"key":"2023_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13023-021-01683-x","volume":"16","author":"R Meyer","year":"2021","unstructured":"Meyer R, Begemann M, H\u00fcbner CT, Dey D, Kuechler A, Elgizouli M, et al. One test for all: whole exome sequencing significantly improves the diagnostic yield in growth retarded patients referred for molecular testing for Silver-Russell syndrome. Orphanet J Rare Dis. 2021;16:42.","journal-title":"Orphanet J Rare Dis"},{"key":"2023_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.969881","volume":"10","author":"P Loid","year":"2022","unstructured":"Loid P, Lipsanen-Nyman M, Ala-Mello S, Hannula-Jouppi K, Kere J, M\u00e4kitie O, et al. Case report: A novel de novo IGF2 missense variant in a Finnish patient with Silver-Russell syndrome. Front Pediatr. 2022;10:969881.","journal-title":"Front Pediatr"},{"key":"2023_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01161","author":"C-L Xia","year":"2019","unstructured":"Xia C-L, Lyu Y, Li C, Li H, Zhang Z-T, Yin S-W, et al. Rare de novo IGF2 variant on the paternal allele in a patient with Silver-Russell syndrome. Front Genet. 2019. https:\/\/doi.org\/10.3389\/fgene.2019.01161.","journal-title":"Front Genet"},{"key":"2023_CR27","unstructured":"\u00d6zdemir BS, Sezer A, Erdeve \u015eS, \u00c7etinkaya S. A Novel IGF2 Gene Variant of Paternal Origin Causing the Silver-Russell Syndrome Phenotype. Horm Res Paediatr. 2023;"},{"key":"2023_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1364234","author":"S Ventresca","year":"2024","unstructured":"Ventresca S, Lepri FR, Criscuolo S, Bottaro G, Novelli A, Loche S, et al. Case report: Long term response to growth hormone in a child with Silver-Russell syndrome-like phenotype due to a novel paternally inherited IGF2 variant. Front Endocrinol (Lausanne). 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1364234.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023_CR29","unstructured":"Durkie M, Cassidy E-J, Berry I, Owens M, Turnbull C, Scott RH, et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2023 Recommendations ratified by ACGS Quality Subcommittee on xxx [Internet]. Royal Devon University Healthcare NHS Foundation Trust. 2023. Available from: https:\/\/www.cangene-canvaruk.org\/gene-specific-recommendations."},{"key":"2023_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2023_CR31","doi-asserted-by":"crossref","unstructured":"Kurup U, Lim DBN, Maharaj A V., Ishida M, Davies JH, Storr HL. Supplemental data: Silver-Russell syndrome secondary to rare (epi)genotypes exhibits phenotypic heterogeneity challenging clinical diagnosis. Mendeley Data. 2025;","DOI":"10.1186\/s13148-025-02023-7"},{"key":"2023_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-020-00140-1","volume":"5","author":"KN James","year":"2020","unstructured":"James KN, Clark MM, Camp B, Kint C, Schols P, Batalov S, et al. Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses. NPJ Genom Med. 2020;5:33.","journal-title":"NPJ Genom Med"},{"key":"2023_CR33","first-page":"1","volume":"2019","author":"AH Sabir","year":"2019","unstructured":"Sabir AH, Ryan G, Mohammed Z, Kirk J, Kiely N, Thyagarajan M, et al. Familial Russell-Silver syndrome like phenotype in the PCNA domain of the CDKN1C gene, a further case. Case Rep Genet. 2019;2019:1\u20138.","journal-title":"Case Rep Genet"},{"key":"2023_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jhg.2015.29","volume":"60","author":"A De Crescenzo","year":"2015","unstructured":"De Crescenzo A, Citro V, Freschi A, Sparago A, Palumbo O, Cubellis MV, et al. A splicing mutation of the HMGA2 gene is associated with Silver-Russell syndrome phenotype. J Hum Genet. 2015;60:287\u201393.","journal-title":"J Hum Genet"},{"key":"2023_CR35","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1210\/clinem\/dgaa273","volume":"105","author":"CT H\u00fcbner","year":"2020","unstructured":"H\u00fcbner CT, Meyer R, Kenawy A, Ambrozaityte L, Matuleviciene A, Kraft F, et al. HMGA2 variants in Silver-Russell syndrome: homozygous and heterozygous occurrence. J Clin Endocrinol Metab. 2020;105:2401\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.gene.2018.04.027","volume":"663","author":"GS Leszinski","year":"2018","unstructured":"Leszinski GS, Warncke K, Hoefele J, Wagner M. A case report and review of the literature indicate that HMGA2 should be added as a disease gene for Silver-Russell syndrome. Gene. 2018;663:110\u20134.","journal-title":"Gene"},{"key":"2023_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169425","author":"AV Maharaj","year":"2024","unstructured":"Maharaj AV, Cottrell E, Thanasupawat T, Joustra SD, Triggs-Raine B, Fujimoto M, et al. Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.169425.","journal-title":"JCI Insight"},{"key":"2023_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01688-w","volume":"16","author":"K Yamoto","year":"2024","unstructured":"Yamoto K, Saitsu H, Ohkubo Y, Kagami M, Ogata T. Pathogenic sequence variant and microdeletion affecting HMGA2 in Silver-Russell syndrome: case reports and literature review. Clin Epigenetics. 2024;16:73.","journal-title":"Clin Epigenetics"},{"key":"2023_CR39","unstructured":"Keselman A, Sanguineti N, Scaglia P, Casali B, Braslavsky D, Azcoiti ME, et al. Familial Silver-Russell like Syndrome with postnatal microcephaly caused by a partial HMGA2 gene deletion. Hormone Research in Paediatrics . 2023;"},{"key":"2023_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s42000-024-00562-x","volume":"23","author":"E Bourousis","year":"2024","unstructured":"Bourousis E, Xatzipsalti M, Polychroni I, Kanavakis E, Stamoyannou L. A variant of uncertain significance of the HMGA2 gene in a child with Silver-Russell syndrome-like phenotype: a case report. Hormones. 2024;23:591\u20133.","journal-title":"Hormones"},{"key":"2023_CR41","unstructured":"Fisch-Shvalb N, Shefer-Averbuch N. A novel heterozygous pathogenic variant in the HMGA2 gene causing Silver-Russell Syndrome, a case-report. Horm Res Paediatr. 2023;"},{"key":"2023_CR42","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2018-02288","volume":"104","author":"L Plachy","year":"2019","unstructured":"Plachy L, Strakova V, Elblova L, Obermannova B, Kolouskova S, Snajderova M, et al. High prevalence of growth plate gene variants in children with familial short stature treated with GH. J Clin Endocrinol Metab. 2019;104:4273\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR43","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1210\/clinem\/dgab177","volume":"106","author":"SA Vishnopolska","year":"2021","unstructured":"Vishnopolska SA, Mercogliano MF, Camilletti MA, Mortensen AH, Braslavsky D, Keselman A, et al. Comprehensive identification of pathogenic gene variants in patients with neuroendocrine disorders. J Clin Endocrinol Metab. 2021;106:1956\u201376.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR44","doi-asserted-by":"crossref","unstructured":"Vado Y, Pereda A, Llano-Rivas I, Gorria-Redondo N, D\u00edez I, Perez de Nanclares G. Novel Variant in PLAG1 in a Familial Case with Silver-Russell Syndrome Suspicion. Genes (Basel). 2020;11.","DOI":"10.3390\/genes11121461"},{"issue":"1","key":"2023_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.gimo.2023.100174","volume":"1","author":"W Chen","year":"2023","unstructured":"Chen W, Gruber A, Kyriss M, Bend E, Sullivan R, Keppler-Noreuil K. P145: Microcephaly in atypical Silver-Russell syndrome caused by defects in PLAG1. Genet Med Open. 2023;1(1):100174.","journal-title":"Genet Med Open"},{"key":"2023_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2023.104837","volume":"66","author":"P Dong","year":"2023","unstructured":"Dong P, Zhang N, Zhang Y, Liu C, Li C. Clinical characterization of PLAG1- related Silver-Russell syndrome: a clinical report. Eur J Med Genet. 2023;66:104837.","journal-title":"Eur J Med Genet"},{"key":"2023_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/pd.6364","volume":"43","author":"WT Tse","year":"2023","unstructured":"Tse WT, Bass C, Gurney L, Kinning E. Maternally inherited autosomal dominant PLAG-1 related Silver Russell syndrome in a fetus with intra-uterine growth restriction. Prenat Diagn. 2023;43:724\u20136.","journal-title":"Prenat Diagn"},{"key":"2023_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jmedgenet-2019-106561","volume":"57","author":"O Lokulo-Sodipe","year":"2020","unstructured":"Lokulo-Sodipe O, Ballard L, Child J, Inskip HM, Byrne CD, Ishida M, et al. Phenotype of genetically confirmed Silver-Russell syndrome beyond childhood. J Med Genet. 2020;57:683\u201391.","journal-title":"J Med Genet"},{"key":"2023_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmedgenet-2013-101693","volume":"50","author":"RP Dias","year":"2013","unstructured":"Dias RP, Nightingale P, Hardy C, Kirby G, Tee L, Price S, et al. Comparison of the clinical scoring systems in Silver-Russell syndrome and development of modified diagnostic criteria to guide molecular genetic testing. J Med Genet. 2013;50:635\u20139.","journal-title":"J Med Genet"},{"key":"2023_CR50","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae730","author":"A Vimercati","year":"2024","unstructured":"Vimercati A, Tannorella P, Guzzetti S, Calzari L, Gentilini D, Manfredini E, et al. Distinguishing genetic alterations versus (Epi)mutations in Silver-Russell syndrome and focus on the IGF1R gene. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae730.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/g3journal\/jkab417","author":"MO Lee","year":"2022","unstructured":"Lee MO, Li J, Davis BW, Upadhyay S, Al Muhisen HM, Suva LJ, et al. Hmga2 deficiency is associated with allometric growth retardation, infertility, and behavioral abnormalities in mice. G3 Genes|Genomes|Genetics. 2022. https:\/\/doi.org\/10.1093\/g3journal\/jkab417.","journal-title":"G3 Genes|Genomes|Genetics"},{"key":"2023_CR52","doi-asserted-by":"crossref","unstructured":"Maharaj A, Cottrell E, Massoud A, Hwa V, Storr H. Dysregulated pathways reveal NOVEL mechanistic insights underlying HMGA2-related growth failure in Silver Russell Syndrome. Endocrine Abstracts. 2023;","DOI":"10.1530\/endoabs.95.OC8.3"},{"key":"2023_CR53","doi-asserted-by":"crossref","unstructured":"Abi Habib W, Brioude F, Azzi S, Rossignol S, Linglart A, Sobrier M-L, et al. Transcriptional profiling at the DLK1\/MEG3 domain explains clinical overlap between imprinting disorders. Sci Adv. 2019;5.","DOI":"10.1126\/sciadv.aau9425"},{"key":"2023_CR54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02589","author":"G Patti","year":"2018","unstructured":"Patti G, Giaccardi M, Capra V, Napoli F, Cangemi G, Notarnicola S, et al. Clinical manifestations and metabolic outcomes of seven adults with Silver-Russell syndrome. J Clin Endocrinol Metab. 2018. https:\/\/doi.org\/10.1210\/jc.2017-02589.","journal-title":"J Clin Endocrinol Metab"},{"key":"2023_CR55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae902","author":"E Giabicani","year":"2025","unstructured":"Giabicani E, Perri\u00e8re A, Netchine I. Silver-Russell syndrome in 2025: is it still a distinct diagnostic entity? J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgae902.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-02023-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02023-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:02:33Z","timestamp":1766455353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-025-02023-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-02023-7","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JHD has received travel bursaries from Pfizer, Novo Nordisk and Sandoz, HLS has received consultancies from Pfizer, Novo Nordisk, Ipsen, Sandoz and Merck and travel bursaries from Pfizer and Novo Nordisk.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}